Zhong Guo Zhi Liang Xin Wen Wang·2025-07-17 07:33Core Insights - The establishment of Meituan's upstream brand advisory committee marks a strategic collaboration with key players in the medical beauty industry, aiming to address industry challenges and enhance consumer trust [1][3][5] Group 1: Committee Formation and Objectives - The advisory committee consists of 12 members, including representatives from the China Association of Plastic Surgery and various upstream medical beauty companies [1] - The committee's focus for the year includes hosting summits, member exchange programs, and creating innovative solutions for industry development [1][3] Group 2: Market Potential and Challenges - The medical beauty market in China is projected to grow from approximately 266.9 billion yuan in 2023 to 309.3 billion yuan in 2024, with an estimated market size of 710.2 billion yuan by 2031, indicating significant growth potential [3] - Over 30% of consumer complaints in the medical beauty sector are related to product quality, highlighting the need for improved standards and practices [3] Group 3: Meituan's Strategic Initiatives - Meituan is enhancing collaboration with upstream brands, having partnered with over 100 brands and covering more than 200 brands to improve supply chain integrity and consumer safety [3][4] - The platform's data and insights are being leveraged to support partners in product launches and marketing strategies, contributing to substantial growth in transaction volumes [4] Group 4: Industry Collaboration and Future Vision - The advisory committee aims to foster a balanced relationship among platforms, brands, institutions, and consumers, promoting sustainable development in the industry [5] - Members of the committee express optimism about Meituan's role in setting aesthetic decision-making standards and integrating brand efforts to enhance consumer value [5]